Michael Schreiber

Michael Schreiber has over 20 years of experience in financial planning and analysis. Michael began their career at Pfizer in 2000 as a Senior Finance Manager in the Finance Shared Services department, where they managed a $100M Global Shared Services Budget and Team. Michael was later promoted to Finance Director of Finance Shared Services and Corporate Development, where they oversaw highly detailed Business Process Outsourcing Projects and Mergers and Acquisitions. In 2014, they moved to Amneal Pharmaceuticals as Associate Director of Financial Planning and Analysis, where they managed the consolidation of the company's Annual Operating Plans, Latest Estimates, Quarter-to-Go Forecasts and Long Range Plans into P&L formats including EBITDA and EPS. In 2019, they joined TELA Bio as a Financial Planning & Analysis Consultant, providing Financial Planning & Analysis support for the Chief Financial Officer of a growing medical technology company with a recently completed Initial Public Offering. Michael then moved to CFGI in 2020 as a Financial Planning and Analysis Consultant. Most recently, they joined Imvax, Inc. in 2021 as their Financial Planning and Analysis Lead.

Michael Schreiber obtained their Master of Business Administration (M.B.A.) from Saint Joseph's University with a focus in Finance. Michael also holds a Bachelor of Science (B.S.) from West Chester University of Pennsylvania, where they were a dual major in Economics and General Business. Michael Schreiber's education began at Cardinal O'Hara High School (Springfield, PA). Additionally, Michael Schreiber is a Project Management Professional (PMP), certified by the Project Management Institute in March 2014.